351 related articles for article (PubMed ID: 27598140)
1. Perillyl Alcohol and Its Drug-Conjugated Derivatives as Potential Novel Methods of Treating Brain Metastases.
Chen TC; Da Fonseca CO; Schönthal AH
Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27598140
[TBL] [Abstract][Full Text] [Related]
2. Intranasal Perillyl Alcohol for Glioma Therapy: Molecular Mechanisms and Clinical Development.
Chen TC; da Fonseca CO; Schönthal AH
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30563210
[TBL] [Abstract][Full Text] [Related]
3. Preliminary results from a phase I/II study of perillyl alcohol intranasal administration in adults with recurrent malignant gliomas.
da Fonseca CO; Schwartsmann G; Fischer J; Nagel J; Futuro D; Quirico-Santos T; Gattass CR
Surg Neurol; 2008 Sep; 70(3):259-66; discussion 266-7. PubMed ID: 18295834
[TBL] [Abstract][Full Text] [Related]
4. The Release of Perillyl Alcohol from the Different Kind of Vehicles.
Miastkowska M; Konieczna M; Lason E; Tabaszewska M; Sikora E; Ogonowski J
Curr Pharm Biotechnol; 2018; 19(7):573-580. PubMed ID: 30062959
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in the molecular genetics of malignant gliomas disclose targets for antitumor agent perillyl alcohol.
da Fonseca CO; Landeiro JA; Clark SS; Quirico-Santos T; da Costa Carvalho Mda G; Gattass CR
Surg Neurol; 2006; 65 Suppl 1():S1:2-1:8; discussion S1:8-1:9. PubMed ID: 16427438
[TBL] [Abstract][Full Text] [Related]
6. How to Make Anticancer Drugs Cross the Blood-Brain Barrier to Treat Brain Metastases.
Angeli E; Nguyen TT; Janin A; Bousquet G
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31861465
[TBL] [Abstract][Full Text] [Related]
7. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
[TBL] [Abstract][Full Text] [Related]
8. The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles?
Juillerat-Jeanneret L
Drug Discov Today; 2008 Dec; 13(23-24):1099-106. PubMed ID: 18848640
[TBL] [Abstract][Full Text] [Related]
9. Improving the transport of chemotherapeutic drugs across the blood-brain barrier.
Orthmann A; Fichtner I; Zeisig R
Expert Rev Clin Pharmacol; 2011 Jul; 4(4):477-90. PubMed ID: 22114857
[TBL] [Abstract][Full Text] [Related]
10. Anaplastic oligodendroglioma responding favorably to intranasal delivery of perillyl alcohol: a case report and literature review.
Da Fonseca CO; Masini M; Futuro D; Caetano R; Gattass CR; Quirico-Santos T
Surg Neurol; 2006 Dec; 66(6):611-5. PubMed ID: 17145324
[TBL] [Abstract][Full Text] [Related]
11. Noninvasive nanoparticle strategies for brain tumor targeting.
Sun C; Ding Y; Zhou L; Shi D; Sun L; Webster TJ; Shen Y
Nanomedicine; 2017 Nov; 13(8):2605-2621. PubMed ID: 28756093
[TBL] [Abstract][Full Text] [Related]
12. A comprehensive review in improving delivery of small-molecule chemotherapeutic agents overcoming the blood-brain/brain tumor barriers for glioblastoma treatment.
Wang D; Wang C; Wang L; Chen Y
Drug Deliv; 2019 Dec; 26(1):551-565. PubMed ID: 31928355
[TBL] [Abstract][Full Text] [Related]
13. Improving drug delivery to primary and metastatic brain tumors: strategies to overcome the blood-brain barrier.
Parrish KE; Sarkaria JN; Elmquist WF
Clin Pharmacol Ther; 2015 Apr; 97(4):336-46. PubMed ID: 25669487
[TBL] [Abstract][Full Text] [Related]
14. Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs.
Agrawal M; Saraf S; Saraf S; Antimisiaris SG; Chougule MB; Shoyele SA; Alexander A
J Control Release; 2018 Jul; 281():139-177. PubMed ID: 29772289
[TBL] [Abstract][Full Text] [Related]
15. Transporter-based delivery of anticancer drugs to the brain: improving brain penetration by minimizing drug efflux at the blood-brain barrier.
On NH; Miller DW
Curr Pharm Des; 2014; 20(10):1499-509. PubMed ID: 23789953
[TBL] [Abstract][Full Text] [Related]
16. Blood-brain barrier and chemotherapeutic treatment of brain tumors.
de Vries NA; Beijnen JH; Boogerd W; van Tellingen O
Expert Rev Neurother; 2006 Aug; 6(8):1199-209. PubMed ID: 16893347
[TBL] [Abstract][Full Text] [Related]
17. Dendrimer technologies for brain tumor.
Mishra V; Kesharwani P
Drug Discov Today; 2016 May; 21(5):766-78. PubMed ID: 26891979
[TBL] [Abstract][Full Text] [Related]
18. New strategies to deliver anticancer drugs to brain tumors.
Laquintana V; Trapani A; Denora N; Wang F; Gallo JM; Trapani G
Expert Opin Drug Deliv; 2009 Oct; 6(10):1017-32. PubMed ID: 19732031
[TBL] [Abstract][Full Text] [Related]
19. Drug delivery to melanoma brain metastases: Can current challenges lead to new opportunities?
Gampa G; Vaidhyanathan S; Sarkaria JN; Elmquist WF
Pharmacol Res; 2017 Sep; 123():10-25. PubMed ID: 28634084
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome in patients with recurrent malignant glioma treated with Perillyl alcohol inhalation.
DA Fonseca CO; Teixeira RM; Silva JC; DE Saldanha DA Gama Fischer J; Meirelles OC; Landeiro JA; Quirico-Santos T
Anticancer Res; 2013 Dec; 33(12):5625-31. PubMed ID: 24324108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
